Renaissance Capital’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-38,752
Closed -$1.5M 90
2023
Q1
$1.5M Sell
38,752
-4,047
-9% -$131K 1.11% 24
2022
Q4
$921K Sell
42,799
-1,445
-3% -$30.2K 0.72% 41
2022
Q3
$1.08M Sell
44,244
-8,276
-16% -$219K 0.7% 39
2022
Q2
$863K Buy
52,520
+19,990
+61% +$388K 0.46% 50
2022
Q1
$874K Sell
32,530
-9,738
-23% -$205K 0.37% 63
2021
Q4
$1.4M Sell
42,268
-7,409
-15% -$280K 0.36% 57
2021
Q3
$2.11M Sell
49,677
-70,859
-59% -$3.81M 0.43% 46
2021
Q2
$7.06M Sell
120,536
-1,369
-1% -$81.5K 1.12% 22
2021
Q1
$6.62M Buy
121,905
+81,318
+200% +$4.52M 0.98% 31
2020
Q4
$2.48M Buy
+40,587
New +$2.13M 0.34% 40

Other funds holding OSH

Renaissance Capital's OSH Position: Q2 2023 in Review

Renaissance Capital sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 38,752 shares — an estimated $1.5M sold.

Renaissance Capital first reported a position in OSH in Q4 2020 and held it in 10 quarters. The position peaked at $7.06M in Q2 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Renaissance Capital reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Renaissance Capital sold 38,752 Oak Street Health, Inc. shares in Q2 2023, an estimated $1.5M.
  • Renaissance Capital first reported a position in Oak Street Health, Inc. in Q4 2020 and held it in 10 quarters.
  • Renaissance Capital's Oak Street Health, Inc. position peaked at $7.06M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Renaissance Capital's 13F filing for Q2 2023, filed 17 Jul 2023.